Stocks

The table gives an overview of all stocks, alphabetically sorted.
 WeSC WESC Jan 21, 2021 2.08 +1.97   
 Westpay WPAY Jan 21, 2021 2.61 -1.88   
 Wihlborgs Fastigheter WIHL Jan 21, 2021 183.40 -2.34   
 Wilh. Wilhelmsen Holding ser. A WWIO Jan 21, 2021 174.00 +4.19   
 WilLak WIL Jan 21, 2021 0.19 +3.26   
 Wise Group WISE Jan 21, 2021 36.90 -3.91   
 WntResearch WNT Jan 21, 2021 1.20 -0.83   
 Wonderful Times Group WTG Jan 21, 2021 14.30 -0.69   
 Wästbygg WBGRB Jan 21, 2021 96.30 0.00   
 Xact Bear XACTBEAR Jan 21, 2021 30.91 -0.63   
 Xact Bear 2 XACTBEAR2 Jan 21, 2021 19.84 -0.79   
 Xact Bull XACTBULL Jan 21, 2021 527.00 +0.63   
 Xact Bull 2 XACTBULL2 Jan 21, 2021 1 071.20 +0.77   
 XACT Högutdelande XACTHDIV Jan 21, 2021 124.24 +0.39   
 Xact OMXS30 XACTOMXS30 Jan 21, 2021 252.25 +0.34   
 XANO Industri B XANOB Jan 21, 2021 151.50 +4.48   
 Xavitech B XAVIB Jan 21, 2021 1.12 -1.75   
 Xbrane Biopharma XBRANE Jan 21, 2021 85.80 +4.89   
 Xintela XINT Jan 21, 2021 3.26 -0.31   
 XMReality XMR Jan 21, 2021 7.70 +3.49   
 Xspray Pharma XSPRAY Jan 21, 2021 122.00 -1.21   
 Xvivo Perfusion XVIVO Jan 21, 2021 293.50 +4.82   
 XXL XXLO Jan 21, 2021 18.90 0.00   
 Yara International YARO Jan 21, 2021 393.30 0.00   
 Zalaris ZALO Jan 21, 2021 51.80 0.00   
 Zaplox ZAPLOX Jan 21, 2021 0.39 -1.02   
 Zenergy B ZENZIPB Jan 21, 2021 0.34 +1.49   
 Zenicor ZENI Jan 21, 2021 12.10 -6.92   
 ZetaDisplay ZETA Jan 21, 2021 16.50 +6.11   
 Ziccum AB ZICC Jan 21, 2021 26.40 -1.86   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK